CD8 blockade promotes the expansion of antigen-specific CD4+ FOXP3+ regulatory T cells in vivo

International Immunopharmacology

Volumn 7, Issue 2, 2007, Pages 249-265

  Wang, Z ^a   Davies, J D ^a  

^a TORREY PINES INSTITUTE FOR MOLECULAR STUDIES   (United States)

Author keywords

CD8 blockade; Monoclonal antibody; Ovalbumin (OVA); Regulatory T cells; TCR transgenic; Tolerance

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G3; INTERLEUKIN 2 RECEPTOR ALPHA; OKT 4; OKT 8; OVALBUMIN; TRANSCRIPTION FACTOR FOXP3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY SPECIFICITY; ANTIGEN SPECIFICITY; ARTICLE; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; CELL SELECTION; CELLULAR IMMUNITY; CONTROLLED STUDY; FEMALE; IMMUNOLOGICAL TOLERANCE; IN VIVO STUDY; ISOGRAFT; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TH1 CELL; TH2 CELL; TRANSGENIC MOUSE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS; ANTIGENS, CD; ANTIGENS, CD4; ANTIGENS, DIFFERENTIATION; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELL SURVIVAL; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; IMMUNOGLOBULIN G; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; OVALBUMIN; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, NERVE GROWTH FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

EID: 33845922650     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2006.10.012     Document Type: Article

References (94)

1. Modigliani Y., Thomas-Vaslin V., Bandeira A., Coltey M., Le Douarin N.M., Coutinho A., et al. Lymphocytes selected in allogeneic thymic epithelium mediate dominant tolerance toward tissue grafts of the thymic epithelium haplotype. Proc Natl Acad Sci U S A 92 (1995) 7555-7559
2. Modigliani Y., Coutinho A., Pereira P., Le Douarin N., Thomas-Vaslin V., Burlen-Defranoux O., et al. Establishment of tissue-specific tolerance is driven by regulatory T cells selected by thymic epithelium. Eur J Immunol 26 (1996) 1807-1815
3. Apostolou I., and von Boehmer H. In vivo instruction of suppressor commitment in naïve T cells. J Exp Med 199 (2004) 1401-1408
4. Mucida D., Kutchukhidze N., Erazo A., Russo M., Lafaille J.J., and Curotto de Lafaille M.A. Oral tolerance in the absence of naturally occurring Tregs. J Clin Invest 115 (2005) 1923-1933
5. Shevach E.M. CD4+CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol 2 (2002) 389-400
6. O'Garra A., Vieira P.L., Veira P., and Goldfeld A.E. IL-10-producing and naturally occurring CD4+ tregs: limiting collateral damage. J Clin Invest 114 (2004) 1372-1378
7. Groux H., O'Garra A., Bigler M., Rouleau M., Antonenko S., de Vries J., et al. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389 (1997) 737-742
8. Levings M., and Roncarolo M. Phenotypic and functional differences between human CD4+ CD25+ and type I regulatory T cells. Curr Top Microbiol Immunol 293 (2005) 303-326
9. Roncarolo M.G., Bacchetta R., Bordignon C., Narula S., and Levings M.K. Type 1 T regulatory cells. Immunol Rev 182 (2001) 68-79
10. Levings M.K., Sangregorio R., Galbiati F., Squadrone S., de Waal Malefyt R., and Roncarolo M. IFN-alpha and IL-10 induce the differentiation of human type1 T regulatory cells. J Immunol 166 (2001) 5530-5539
11. Vieira P.L., Christensen J.R., Minaee S., O'Neill E.J., Barrat F.J., Boonstra A., et al. IL-10-secreting regulatory T cells do not express FOXP3 but have comparable regulatory function to naturally occurring CD4+CD25+ regulatory T cells. J Immunol 172 (2004) 5986-5993
12. Levings M.K., Gregori S., Tresoldi E., Cazzaniga S., Bonini C., and Roncarolo M. Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25+CD4+ Tr cells. Blood 105 (2005) 1162-1169
13. Karagiannidis C., Akdis M., Holopainen P., Woolley N.J., Hense G., Ruckert B., et al. Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma. J Allergy Clin Immunol 114 (2004) 1425-1433
14. Martins T.C., and Aguas A.P. A role for CD45RBlow CD38+ T cells and costimulatory pathways of T-cell activation in protection of non-obese diabetic (NOD) mice from diabetes. Immunology 96 (1999) 600-605
15. Bach J.F., and Chatenoud L. Tolerance to islet autoantigens in type 1 diabetes. Annu Rev Immunol 19 (2001) 131-161
16. Lepault F., and Gagnerault M.C. Characterization of peripheral regulatory CD4+ T cells that prevent diabetes onset in nonobese diabetic mice. J Immunol 164 (2000) 240-247
17. Shimuzu J., Yamazaki S., Takahashi T., Ishida Y., and Sakaguchi S. Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance. Nat Immunol 3 (2002) 135-142
18. Takahashi T., Tagami T., Yamazaki S., Uede T., Shimizu J., Sakaguchi N., et al. Immunologic self tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med 192 (2000) 303-310
19. Read S., Malstrom V., and Powrie F. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory T cells that control intestinal inflammation. J Exp Med 192 (2000) 295-302
20. Powrie F., Leach M.W., Mauze S., Caddle L.B., and Coffman R.L. Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C.B-17 scid mice. Int Immunol 5 (1993) 1461-1471
21. Morrissey P.J., Charrier K., Braddy S., Liggitt D., and Watson J.D. CD4+ T cells that express high levels of CD45RB induce wasting disease when transferred into congenic severe combined immunodeficient mice. Disease development is prevented by cotransfer of purified CD4+ T cells. J Exp Med 178 (1993) 237-244
22. + CD45RB low-density cells from untreated mice prevent acute allograft rejection. J Immunol 163 (1999) 5353-5357
23. Hara M., Kingsley C.I., Niimi M., Read S., Turvey S.E., Bushell A.R., et al. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J Immunol 166 (2001) 3789-3796
24. Mathew J.M., Fuller L., Carreno M., Garcia-Morales R., Burke III G.W., Ricordi C., et al. Involvement of multiple subpopulations of human bone marrow cells in the regulation of allogeneic cellular immune responses. Transplantation 70 (2000) 1752-1760
25. Jiang S., Herrera O., and Lechler R.I. New spectrum of allorecognition pathways: implications for graft rejection and transplantation tolerance. Curr Opin Immunol 16 (2004) 550-557
26. Waldmann T.A. The multi-subunit interleukin-2 receptor. Annu Rev Biochem 58 (1989) 875-911
27. Jackson D.G., and Bell J.I. Isolation of a cDNA encoding the human CD38 (T10) molecule, a cell surface glycoprotein with an unusual discontinuous pattern of expression during lymphocyte differentiation. J Immunol 144 (1990) 2811-2815
28. Budd R.C., Cerottini J.C., Horvath C., Bron C., Pedrazzini T., Howe R., et al. Distinction of virgin and memory T lymphocytes: stable acquisition of the Pgp-1 glycoprotein concomitant with antigenic stimulation. J Immunol 138 (1987) 3120-3129
29. Swain S.L. Generation and in vivo persistence of polarized Th1 and Th2 memory cells. Immunity 1 (1994) 543-552
30. Birkeland M.L., Johnson P., Trowbridge I.S., and Pure E. Changes in CD45 isoform expression accompany antigen-induced murine T-cell activation. Proc Natl Acad Sci U S A 86 (1989) 6734-6738
31. Bottomly K., Luqman M., Greenbaum L., Carding S., West J., Pasqualini T., et al. A monoclonal antibody to murine CD45R distinguishes CD4 T cell populations that produce different cytokines. Eur J Immunol 19 (1989) 617-623
32. Lee W.T., Yin X.M., and Vitetta E.S. Functional and ontogenic analysis of murine CD45Rhi and CD45Rlo CD4+ T cells. J Immunol 144 (1990) 3288-3295
33. Foy T.F., Aruffo A., Bajorath J., Buhlmann J.E., and Noelle R.J. Immune regulation by CD40 and its ligand GP39. Annu Rev Immunol 14 (1996) 591-617
34. Lenschow D.J., Walunas T.L., and Bluestone J.A. The CD28/B7 system of T-cell costimulation. Annu Rev Immunol 14 (1996) 233-258
35. Qin S.X., Cobbold S., Benjamin R., and Waldmann H. Induction of classical transplantation tolerance in the adult. J Exp Med 169 (1989) 779-794
36. Honey K., Cobbold S.P., and Waldmann H. CD40 ligand blockade induces CD4+ T cell tolerance and linked suppression. J Immunol 163 (1999) 4805-4810
37. Ensminger S.M., Witzke O., Spriewald B.M., Morrison K., Morris P.J., Rose M., et al. CD8+ T cells contribute to the development of transplant arteriosclerosis despite CD154 blockade. Transplantation 69 (2000) 2609-2612
38. Rossini A.A., Mordes J.P., Greiner D.L., and Stoff J.S. Islet cell transplantation tolerance. Transplantation 72 (2001) 43-46
39. Newell K.A., He G., Guo Z., Kim O., Szot G.L., Rulifson I., et al. Blockade of the CD28/B7 costimulatory pathway inhibits intestinal allograft rejection mediated by CD4+ but not CD8+ T cells. J Immunol 163 (1999) 2358-2362
40. Qin S., Cobbold S.P., Pope H., Elliott J., Kioussis D., Davies J., et al. "Infectious" transplantation tolerance. Science 259 (1993) 974-977
41. Watson C.J., Cobbold S.P., Davies H.S., Rebello P.R., Waldmann H., Calne R., et al. CD4 and CD8 monoclonal antibody therapy: strategies to prolong renal allograft survival in the dog. Br J Surg 80 (1993) 1389-1392
42. Baron F., Baudoux E., Frere P., Tourqui S., Schaaf-Lafontaine N., Greimers R., et al. Nonmyeloablative stem cell transplantation with CD8-depleted or CD34-selected peripheral blood stem cells. J Hematother Stem Cell Res 11 (2002) 301-314
43. Soiffer R.J., Alyea E.P., Hochberg E., Wu C., Canning C., Parikh B., et al. Randomized trial of CD8+ T-cell depletion in the prevention of graft-versus-host disease associated with donor lymphocyteinfusion. Biol Blood Marrow Transplant 8 (2002) 625-632
44. Cobbold S.P., Martin G., and Waldmann H. The induction of skin graft tolerance in major histocompatibility complex-mismatched or primed recipients: primed T cells can be tolerized in the periphery with anti-CD4 and anti-CD8 antibodies. Eur J Immunol 20 (1990) 2747-2755
45. Qin S.X., Wise M., Cobbold S.P., Leong L., Kong Y.C., Parnes J.R., and Waldmann H. Induction of tolerance in peripheral T cells with monoclonal antibodies. Eur J Immunol 20 (1990) 2737-2745
46. Chen Z., Cobbold S., Metcalfe S., and Waldman H. Tolerance in the mouse to major histocompatibility complex-mismatched heart allografts, and to rat heart xenografts, using monoclonal antibodies to CD4 and CD8. Eur J Immunol 22 (1992) 805-810
47. Davies J.D., Leong L.Y., Mellor A., Cobbold S.P., and Waldmann H. T cell suppression in transplantation tolerance through linked recognition. J Immunol 156 (1996) 3602-3607
48. Davies J.D., Martin G., Phillips J., Marshall S.E., Cobbold S.P., and Waldmann H. T cell regulation in adult transplantation tolerance. J Immunol 157 (1996) 529-533
49. Sher A., and Coffman R.L. Regulation of immunity to parasites by T cells and T cell-derived cytokines. Annu Rev Immunol 10 (1992) 385-409
50. Abbas A.K., Murphy K.M., and Sher A. Functional diversity of helper T lymphocytes. Nature 383 (1996) 787-793
51. Romagnani S. Human Th1 and Th2 subsets: doubt no more. Immunol Today 12 (1991) 256-257
52. O'Connell P.J., Pacheco-Silva A., Nickerson P.W., Muggia R.A., Bastos M., Kelley V., et al. Unmodified pancreatic islet allograft rejection results in the preferential expression of certain T cell activation transcripts. J Immunol 150 (1993) 1093-1104
53. Dallman M.J., Larsen C.P., and Morris P.J. Cytokine gene transcription in vascularised organ grafts: analysis using semiquantitative polymerase chain reaction. J Exp Med 174 (1991) 493-496
54. Nickerson P., Steurer W., Steiger J., Zheng X., Steele A.W., Strom T., et al. Cytokines and the Th1/Th2 paradigm in transplantation. Curr Opin Immunol 6 (1994) 757-764
55. Bugeon L., Cuturi M.C., Hallet M.M., Paineau J., Chabannes D., and Soulillou J. Peripheral tolerance of an allograft in adult rats-characterization by low interleukin-2 and interferon-gamma mRNA levels and by strong accumulation of major histocompatibility complex transcripts in the graft. Transplantation 54 (1992) 219-225
56. Tellides G., Dallman M.J., and Morris P.J. Mechanism of action of interleukin-2 receptor (IL-2R) monoclonal antibody (Mab) therapy: target cell depletion or inhibition of function?. Transplant Proc 21 (1989) 997-998
57. Kupiec-Weglinski J.W., Diamantstein T., and Tilney N.L. Interleukin 2 receptor-targeted therapy-rationale and application in organ transplantation. Transplantation 46 (1988) 785-792
58. Murphy K.M., Heimberger A.B., and Loh D.Y. Induction by antigen of intrathymic apoptosis of CD4+ CD8+ TCRlo thymocytes in vivo. Science 250 (1990) 1720-1723
59. Haskins K., Kubo R., White J., Pigeon M., Kappler J., and Marrak P. The major histocompatibility complex-restricted antigen receptor on T cells. I. Isolation with a monoclonal antibody. J Exp Med 157 (1983) 1149-1169
60. Kearney E.R., Pape K.A., Loh D.Y., and Jenkins M.K. Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity 1 (1994) 327-339
61. Pape K.A., Khoruts A., Ingulli E., Mondino A., Merica R., and Jenkins M. Antigen-specific CD4+ T cells that survive after the induction of peripheral tolerance possess an intrinsic lymphokine production defect. Novartis Found Symp 215 (1998) 103-113
62. Isakson P.C., Pure E., Vitetta E.S., and Krammer P.H. T cell-derived B cell differentiation factor(s). Effect on the isotype switch of murine B cells. J Exp Med 155 (1982) 734-748
63. Pene J., Rousset F., Briere F., Chretien I., Paliard X., Banchereau J., et al. IgE production by normal human B cells induced by alloreactive T cell clones is mediated by IL-4 and suppressed by IFN-gamma. J Immunol 141 (1988) 1218-1224
64. Coffman R.L., and Carty J. A T cell activity that enhances polyclonal IgE production and its inhibition by interferon-gamma. J Immunol 136 (1986) 949-954
65. Snapper C.M., McIntyre T.M., Mandler R., Pecanha L.M., Finkelman F.D., Lees A., et al. Induction of IgG3 secretion by interferon gamma: a model for T cell-independent class switching in response to T cell-independent type 2 antigens. J Exp Med 175 (1992) 1367-1371
66. Snapper C.M., and Paul W.E. Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 236 (1987) 944-947
67. Coffman R.L., Lebman D.A., and Shrader B. Transforming growth factor beta specifically enhances IgA production by lipopolysaccharide-stimulated murine B lymphocytes. J Exp Med 170 (1989) 1039-1044
68. Briere F., Servet-Delprat C., Bridon J.M., Saint-Remy J.M., and Banchereau J. Human interleukin 10 induces naive surface immunoglobulin D+(sIgD+) B cells to secrete IgG1 and IgG3. J Exp Med 179 (1994) 757-762
69. Lorenz M., Jung S., and Radbruch A. Switch transcripts in immunoglobulin class switching. Science 267 (1995) 1825-1828
70. Weigle W.O. Immunological unresponsiveness. Adv Immunol 16 (1973) 61-122
71. Frei P.C., Benacerraf B., and Thorbecke G.J. Phagocytosis of the antigen, a crucial step in the induction of the primary response. PNAS 53 (1965) 20-23
72. Dresser W. Effectiveness of lipid and lipidophilic substances as adjuvants. Nature 191 (1961) 1169-1171
73. Krauth J. The interpretation of significance test for independence and dependent samples. J Neurosci Methods 9 (1983) 269-281
74. Ludbrook J., and Dudley H. Issues in biomedical statistics: analyzing 2 × 2 tables of frequencies. Aust N Z J Surg 64 (1994) 780-787
75. Benjamin R.J., Cobbold S.P., Clark M.R., and Waldmann H. Tolerance to rat monoclonal antibodies. Implications for serotherapy. J Exp Med 163 (1986) 1539-1552
76. Nag B., Wada H.G., Passmore D., Clark B.R., Sharma S.D., and McConnell H.M. Purified beta-chain of MHC class II binds to CD4 molecules on transfected HeLa cells. J Immunol 150 (1993) 1358-1364
77. Blue M.L., Hafler D.A., Daley J.F., Levine H., Craig K.A., Breitmeyer J., et al. Regulation of T cell clone function via CD4 and CD8 molecules. Anti-CD4 can mediate two distinct inhibitory activities. J Immunol 140 (1988) 376-383
78. Bonnard M., Haughn L., and Julius M. CD4-mediated inhibiton of IL-2 production in activated T cells. J Immunol 162 (1999) 1252-1260
79. Longhi M.S., Hussain M.J., Mitry R.R., Arora S.K., Mieli-Vergani G., Vergani D., et al. Functional study of CD4+CD25+ regulatory T cells in health and autoimmune hepatitis. J Immunol 176 (2006) 4484-4491
80. Stassen M., Jonuleit H., Muller C., Klein M., Richter C., Bopp T., et al. Differential regulatory capacity of CD25+ T regulatory cells and preactivated CD25+ T regulatory cells on development, functional activation, and proliferation of Th2 cells. J Immunol 173 (2004) 267-274
81. Skapenko A., Kalden J.R., Lipsky P.E., and Schulze-Koops H. The IL-4 receptor alpha-chain-binding cytokines, IL-4 and IL-13, induce forkhead box P3-expressing CD25+CD4+ regulatory T cells from CD25-CD4+ precursors. J Immunol 175 (2005) 6107-6116
82. Vikingsson A., Pederson K., and Muller D. Altered kinetics of CD4+ T cells proliferation and interferon-g production in the absence of CD8+ T lymphocytes in virus-infected b2-microglobulin-deficient mice. Cell Immunol 173 (1996) 261-268
83. Xystrakis E., Dejean A.S., Bernard I., Druet P., Liblau R., Gonzalez-Dunia D., et al. Identification of a novel regulatory CD8 T-cell subset and analysis of its mechanism of regulation. Blood 104 (2004) 3294-3301
84. Stock P., Kallinich T., Akbari O., Quarcoo D., Gerhold G., Wahn U., et al. CD8+ T cells regulate immune responses in a murine model of allergen-induced sensitization and airway inflammation. Eur J Immunol 34 (2004) 1817-1827
85. Wu Z., Bensinger S.J., Zhang J., Chen C., Yuan X., Huang X., et al. Homeostatic proliferation is a barrier to transplantation tolerance. Nat Med 10 (2004) 87
86. Tanchot C., Rosado M.M., Agenes F., Freitas A.A., and Rocha B. Lymphocyte homeostasis. Semin Immunol 9 (1997) 331
87. King C., Ilic A., Koelsch K., and Sarvetnick N. Homeostatic expansion of T cells during immune insufficiency generates autoimmunity. Cell 117 (2004) 265
88. Vremec D., Zorbas M., Scollay R., Saunders D.J., Ardavin C.F., Wu L., et al. The surface phenotype of dendritic cells purified from mouse thymus and spleen: investigation of the CD8 expression by a subpopulation of dendrtic cells. J Exp Med 176 (1992) 47-58
89. Bilsborough J., George T.C., Norment A., and Viney J.L. Mucosal CD8a+DC, with a plasmacytoid phenotype, induce differentiation and support function of T cells with regulatory properties. Immunology 108 (2003) 481-492
90. O'Connell P.J., Li W., Wang Z., Specht S.M., Logar A.J., and Thomson A.W. Immature and mature CD8a+ dendritic cells prolong the survival of vasculatized heart allografts. J Immunol 168 (2002) 143-154
91. Suss G., and Shortman K. A subclass of dendritic cells kills CD4 T cells via Fas/Das ligand-induced apoptosis. J Exp Med 183 (1996) 1789-1796
92. Lambolez F., Jooss K., Vasseur F., and Sarukhan A. Tolerance induction to self antigens by peripheral dendritic cells. Eur J Immunol 32 (2002) 2588-2597
93. Maldonado-Lopez R., De Smedt T., Michel P., Godfroid J., Pajak B., Heirman C., et al. CD8a+ and CD8a-subclasses of dendritic cells direct the development of distinct T helper cells in vivo. J Exp Med 189 (1999) 587-592
94. Maldonado-Lopez R., De Smedt T., Pajak B., Michel P., Heirman C., Leo O., et al. Role of CD8a+ and CD8a-dendritic cells in the induction of primary immune responses in vivo. J Leukoc Biol 66 (1999) 242-246